Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 3 , Pages 200-206 , September 2006

Combination of viral biology and nanotechnology: new applications in nanomedicine

  • Vaibhav Saini, MSc

      Affiliations

    • Division of Human Gene Therapy, Departments of Medicine, Surgery, Pathology and the Gene Therapy Center, University of Alabama at Birmingham, Birmingham, Alabama, USA
    • Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama, USA
    • ,
  • Vladimir P. Zharov, PhD

      Affiliations

    • Philips Classic Laser Laboratories, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
    • ,
  • Christopher S. Brazel, PhD

      Affiliations

    • Center for Materials for Information Technology (MINT), University of Alabama, Tuscaloosa, Alabama, USA
    • ,
  • David E. Nikles, PhD

      Affiliations

    • Center for Materials for Information Technology (MINT), University of Alabama, Tuscaloosa, Alabama, USA
    • ,
  • Duane T. Johnson, PhD

      Affiliations

    • Center for Materials for Information Technology (MINT), University of Alabama, Tuscaloosa, Alabama, USA
    • ,
  • Maaike Everts, PhD

      Affiliations

    • Division of Human Gene Therapy, Departments of Medicine, Surgery, Pathology and the Gene Therapy Center, University of Alabama at Birmingham, Birmingham, Alabama, USA
    • Corresponding Author InformationCorresponding author. Division of Human Gene Therapy, Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35294-2180.

Received 14 February 2006 ,Accepted 19 July 2006.

References 

  1. Douglas T, Young M. Host-guest encapsulation of materials by assembled virus protein cages. Nature. 1998;393:152–155
  2. Mao C, et al. Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science. 2004;303:213–217
  3. Hartgerink JD, Beniash E, Stupp SI. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science. 2001;294:1684–1688
  4. Reches M, Gazit E. Casting metal nanowires within discrete self-assembled peptide nanotubes. Science. 2003;300:625–627
  5. Weizmann Y, et al. Magneto-mechanical detection of nucleic acids and telomerase activity in cancer cells. J Am Chem Soc. 2004;126:1073–1080
  6. Huang Y, et al. Programmable assembly of nanoarchitectures using genetically engineered viruses. Nano Lett. 2005;5:1429–1434
  7. Radloff C, et al. Metal nanoshell assembly on a virus bioscaffold. Nano Lett. 2005;5:1187–1191
  8. Mao C, et al. Viral assembly of oriented quantum dot nanowires. Proc Natl Acad Sci U S A. 2003;100:6946–6951
  9. Reiss BD, et al. Biological routes to metal alloy Fefrromagnetic nanostructures. Nano Lett. 2004;4:1127–1132
  10. Lee SK, Yun DS, Belcher AM. Cobalt ion mediated self-assembly of genetically engineered bacteriophage for biomimetic co-pt hybrid material. Biomacromolecules. 2006;7:14–17
  11. Falkner JC. et al. Virus crystals as nanocomposite scaffolds. J Am Chem Soc. 2005;127:5274–5275
  12. Chiu W, Burnett RM, Garcea R. Structural biology of viruses. New York: Oxford University Pressm; 1997;
  13. Dragnea B, et al. Gold nanoparticles as spectroscopic enhancers for in vitro studies on single viruses. J Am Chem Soc. 2003;125:6374–6375
  14. Cheung CL, et al. Fabrication of assembled virus nanostructures on templates of chemoselective linkers formed by scanning probe nanolithography. J Am Chem Soc. 2003;125:6848–6849
  15. Aoyama Y. Macrocyclic glycoclusters: from amphiphiles through nanoparticles to glycoviruses. Chemistry. 2004;10:588–593
  16. Osaki F, et al. A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. J Am Chem Soc. 2004;126:6520–6521
  17. Valanne A, et al. A sensitive adenovirus immunoassay as a model for using nanoparticle label technology in virus diagnostics. J Clin Virol. 2005;33:217–223
  18. Wang YF, et al. Visual gene diagnosis of HBV and HCV based on nanoparticle probe amplification and silver staining enhancement. J Med Virol. 2003;70:205–211
  19. Taton TA, Mirkin CA, Letsinger RL. Scanometric DNA array detection with nanoparticle probes. Science. 2000;289:1757–1760
  20. Perez JM, et al. Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. J Am Chem Soc. 2003;125:10192–10193
  21. Perez JM, Josephson L, Weissleder R. Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. Chembiochem. 2004;5:261–264
  22. Harisinghani MG, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348:2491–2499
  23. Patolsky F, et al. Electrical detection of single viruses. Proc Natl Acad Sci U S A. 2004;101:14017–14022
  24. Sahloff EG. Current issues in the development of a vaccine to prevent human immunodeficiency virus: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2005;25:741–747
  25. Ulmer JB, Sadoff JC, Liu MA. DNA vaccines. Curr Opin Immunol. 1996;8:531–536
  26. Locher CP, et al. Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation. Immunol Lett. 2003;90:67–70
  27. Shephard MJ, et al. Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice. Res Vet Sci. 2003;74:187–190
  28. Scheidler A, et al. Inactivation of viruses by beta-propiolactone in human cryo poor plasma and IgG concentrates. Biologicals. 1998;26:135–144
  29. Preuss T, et al. Comparison of two different methods for inactivation of viruses in serum. Clin Diagn Lab Immunol. 1997;4:504–508
  30. Ng PK, Dobkin MB. Pasteurization of antihemophilic factor and model virus inactivation studies. Thromb Res. 1985;39:439–447
  31. Savage M, et al. Determination of adequate moisture content for efficient dry-heat viral inactivation in lyophilized factor VIII by loss on drying and by near infrared spectroscopy. Biologicals. 1998;26:119–124
  32. Omar A, Kempf C. Removal of neutralized model parvoviruses and enteroviruses in human IgG solutions by nanofiltration. Transfusion. 2002;42:1005–1010
  33. Burnouf T, Radosevich M. Nanofiltration of plasma-derived biopharmaceutical products. Haemophilia. 2003;9:24–37
  34. Van der Bruggen B, Vandecasteele C. Removal of pollutants from surface water and groundwater by nanofiltration: overview of possible applications in the drinking water industry. Environ Pollut. 2003;122:435–445
  35. Stoff-Khalili MA, Dall P, Curiel DT. From gene therapy to virotherapy for ovarian cancer. Minerva Ginecol. 2004;56:503–514
  36. Ono HA, et al. Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer. J Gastroenterol. 2005;40:31–42
  37. Bateman A, et al. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res. 2000;60:1492–1497
  38. Flotte TR. Adeno-associated virus-based gene therapy for inherited disorders. Pediatr Res. 2005;58:1143–1147
  39. Blankinship MJ, Gregorevic P, Chamberlain JS. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors. Mol Ther. 2006;13:241–249
  40. Gerolami R, et al. Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact. Cancer Gene Ther. 2003;10:649–660
  41. Everts M, Curiel DT. Transductional targeting of adenoviral cancer gene therapy. Curr Gene Ther. 2004;4:337–346
  42. O'Neal DP, et al. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209:171–176
  43. Zharov VP, et al. Self-assembling nanoclusters in living systems: application for integrated photothermal nanodiagnostics and nanotherapy. Nanomedicine. 2005;1:326–345
  44. Hilger I, et al. Magnetic thermotherapy of breast tumors: an experimental therapeutic approach. Rofo Fortschr Geb Roentgenstr Neuen Bildgeb Verfahr. 2005;177:507–515

 Conflict of Interest: The authors declare that they have no conflict of interest.

PII: S1549-9634(06)00100-6

doi: 10.1016/j.nano.2006.07.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 3 , Pages 200-206 , September 2006

Article Tools

* Image Usage & Resolution